Population pharmacokinetic model of ibrutinib, a Bruton tyrosine kinase inhibitor, in patients with B cell malignancies

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, November 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 3,031 followers.

#lymphoma #endcancer Population pharmacokinetic model of #ibrutinib in patients with B cell malignancies http://t.co/F92jolvnNA

#lymphoma #endcancer Population pharmacokinetic model of #ibrutinib in patients with B cell malignancies http://t.co/F92jolvnNA